A main component of SCFA-sodium butyrate through its HDAC-inhibiting ability can promote the expression of anti-inflammatory (IL-10) genes and the downstream IL-10/STAT3 pathway in microglia, which can positively promote neurogenesis and axonal growth after a stroke insult (116). Here, IL10 is linked to stroke disorder.